Your browser doesn't support javascript.
loading
Amplifying colorectal cancer progression: impact of a PDIA4/SP1 positive feedback loop by circPDIA4 sponging miR-9-5p.
Zhuang, Yan; Ai, Yiding; Li, Peng; Yue, Xin; Li, Yue; Shan, Luling; Wang, Tongtong; Zhao, Peng; Jin, Xun.
Affiliation
  • Zhuang Y; Department of Colorectal Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060, China.
  • Ai Y; Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060, China.
  • Li P; Department of Neurosurgery and Neuro-Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060, China.
  • Yue X; Department of Colorectal Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060, China.
  • Li Y; Department of Gastro Colorectal Oncology, Tianjin Cancer Hospital Airport Hospital, Tianjin 300308, China.
  • Shan L; Department of Gastro Colorectal Oncology, Tianjin Cancer Hospital Airport Hospital, Tianjin 300308, China.
  • Wang T; Department of Gastro Colorectal Oncology, Tianjin Cancer Hospital Airport Hospital, Tianjin 300308, China.
  • Zhao P; Department of Gastro Colorectal Oncology, Tianjin Cancer Hospital Airport Hospital, Tianjin 300308, China.
  • Jin X; Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060, China.
Cancer Biol Med ; 2024 Jun 21.
Article in En | MEDLINE | ID: mdl-38907517
ABSTRACT

OBJECTIVE:

Colorectal cancer (CRC) is a prevalent malignant tumor with a high fatality rate. CircPDIA4 has been shown to have a vital role in cancer development by acting as a facilitator. Nevertheless, the impact of the circPDIA4/miR-9-5p/SP1 axis on development of CRC has not been studied.

METHODS:

Western blot, immunohistochemistry, and reverse transcription-quantitative polymerase chain reaction assays were used to analyze gene expression. The CCK-8 assay was used to assess cell growth. The Transwell assay was used to detect invasion and migration of cells. The luciferase reporter and RNA immunoprecipitation tests were used to determine if miR-9-5p and circPDIA4 (or SP1) bind to one another. An in vivo assay was used to measure tumor growth.

RESULTS:

It was shown that circPDIA4 expression was greater in CRC cell lines and tissues than healthy cell lines and tissues. CircPDIA4 knockdown prevented the invasion, migration, and proliferation of cells in CRC. Additionally, the combination of circPDIA4 and miR-9-5p was confirmed, as well as miR-9-5p binding to SP1. Rescue experiments also showed that the circPDIA4/miR-9-5p/SP1 axis accelerated the development of CRC. In addition, SP1 combined with the promoter region of circPDIA4 and induced circPDIA4 transcription. CircPDIA4 was shown to facilitate tumor growth in an in vivo assay.

CONCLUSIONS:

The circPDIA4/miR-9-5p/SP1 feedback loop was shown to aggravate CRC progression. This finding suggests that the ceRNA axis may be a promising biomarker for CRC patient treatment.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Biol Med Year: 2024 Document type: Article Affiliation country: China Country of publication: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Biol Med Year: 2024 Document type: Article Affiliation country: China Country of publication: China